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Abstract 
Background: Neonatal sepsis is a life-threatening medical condition that occurs when host and pathogen interaction 
leads to organ/tissue damage. Determining the bacterial profile and the antimicrobial susceptibility pattern, and 
associated factors, in certain geographic regions is vital for rapid empirical medical decisions. 
Objective: To assess the bacterial profile, antimicrobial susceptibility pattern, and factors associated with neonatal 
sepsis, in Felege-Hiwot Referral Hospital, Ethiopia.  
Methods: A facility-based cross-sectional study was conducted from April 2018 to July 2018. A total of 412 
neonates were included in the study. Socio-demographic and clinical data were collected using a structured and pre-
tested questionnaire. About 2ml of blood sample was withdrawn from each participant, and processed for bacterial 
identification and susceptibility testing, following 2017 Clinical and Laboratory Standards Institute guidelines. Data 
were analysed using Statistical Package for the Social Sciences version 23. Logistic regressions were used to 
determine the association between independent variables and dependent variables in relation to bacterial profiles 
and antimicrobial susceptibility patterns. Odds ratios, and their 95% confidence intervals, were calculated, and the 
results were considered statistically significant at a p-value less than 0.05.   
Results: Of the 412 neonates who were enrolled, 41.3% (170/412) were positive for blood culture. Klebsiella 
pneumoniae, 28.2% (48/170) was the predominant isolate, followed by Staphylococcus aureus, 24.7% (42/170). The 
majority of the isolates developed resistance to ampicillin and penicillin. The overall proportion of multidrug 
resistance was 78.2% (133/170). Preterm (<37 weeks) [AOR = 2.049; 95% CI: 1.151, 3.647], low birth weight 
(<2,500gm) [AOR = 2.357; 95% CI: 1.352, 4.109], prolonged rupture of membrane (≥18 hours) [AOR = 4.282; 95% 
CIL: 1.615, 11.354], and caesarean section modes of delivery [AOR = 2.826; 95% CI: 1.618, 4.936] showed 
statistical association with bacteriologically confirmed neonatal sepsis. 
Conclusions: The majority (78.2%) of presumptive neonatal sepsis cases tested positive for blood culture. Klebsiella 
pneumoniae and Staphylococcus aureus were the leading isolates recovered from neonatal sepsis cases. Most of the 
bacterial isolates from NS cases were resistant to multiple classes of antibiotic. Auspiciously, majority of these 
isolates were susceptible to ciprofloxacin; as such this replication inhibitor antibiotic could be a choice of physicians 
for empirical treatment decision. Since it is a single facility based study, further study is recommended. [Ethiop. J. 
Health Dev. 2021; 35(1):18-28]   
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Introduction  
Neonatal sepsis (NS) is a blood infection that occurs in 
an infant less than 90 days old. NS is the cause of 
substantial mortality and morbidity (1). Based on the 
onset time of symptoms, NS is classified as either early-
onset neonatal sepsis (EONS) or late-onset neonatal 
sepsis (LONS) (2,3). The EONS is defined as sepsis that 
developed within 72 hours of life, and is mainly 
associated with organisms acquired before and during 
delivery (3,4). Whereas, LONS occurs after the first 
three days of life and the organisms are mostly acquired 
after delivery (5,6). 
 
The burden of neonatal death is unevenly distributed 
across the globe, with the highest magnitude in 
developing countries (7). According to a UNICEF 
global report in 2016, neonatal death rates globally and 
in Africa were 1.9% and 2.7%, respectively (8). 
Majority of the newborn deaths occurred in the two 
regions, at which 39% and 38% accounted in southern 
Asia and sub-Saharan Africa, respectively. Moreover, 
India (24%), Pakistan (10%), Nigeria (9%), Democratic 
Republic of Congo (4%) and Ethiopia (3%) were the 
five countries accounted half of all the newborn deaths 
(8). In Ethiopia, the neonatal mortality rate is 29 per 
1,000 live births, which is higher than the average global 
death rate (19 per 1,000 live births) (9).  
 
Different studies have shown that prolonged rupture of 
membrane (PROM) (≥18 hours), urinary tract infection 
(UTI), invasive procedures, and colonization by Group 
B Streptococcus (GBS) are maternal factors associated 
with NS (6). Additionally, low birth weight (LBW), low 
appearance, pulse, grimace, activity and respiration 
(APGAR) scores, poor hygiene and poor cord care 
(6,10) showed associations with NS, confirming the 
multiple factors responsible for NS. The APGAR score 
is used to assess the health status of the new born within 
a few minutes of birth. Any score below seven is an 
indicator of some pathology (10). It is measured within 
one- and five-minute intervals, immediately after the 
mother has delivered. One of the authors of this paper, a 
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paediatrician, reviewed the literature, and recommended 
the classification stated in the ‘Results’ section.    
 
Evidence confirms the link between drug-resistant 
pathogens and the mortality of neonates (11). As such, 
ampicillin/penicillin with gentamicin combination 
therapy is considered as the first line of treatment choice 
(12). Such empirical combination therapy comes from 
periodic surveillance of pathogens and associated 
antimicrobials. Hence, the aim of the current study was 
to assess the bacterial profile, antimicrobial 
susceptibility pattern and factors associated with NS in 
Felege-Hiwot Referral Hospital (FHRH).  
 
Materials and methods 
Study design, period and setting: A hospital-based 
cross-sectional study was conducted from April to July 
2018 at Felege-Hiwot Referral Hospital (FHRH). FHRH 
is located in Bahir Dar, Amhara National Regional 
State, Ethiopia, about 565km from Addis Ababa, the 
capital city of Ethiopia. Nearly 1,350 NS cases are 
admitted and diagnosed annually in the hospital 
(Unpublished data of FHRH).  
 
Study population: The study population comprised all 
neonates presumptive to sepsis and who attended FHRH 
during the study period. All neonates with clinical signs 
and symptoms of sepsis who had not been administered 
antibiotics during the data collection period were 
eligible. The sample size (N) was calculated using a 
single population proportion formula and taking 46.6% 
prevalence from a previous study done at Gondar 
University Hospital, Ethiopia (14); 95% certainty and 
5% degree of freedom. Hence, the minimum sample size 
was set at 412, and participants were conveniently 
recruited until the intended sample size was complete.  
 
Data collection – Socio-demographic and clinical 
data: Socio-demographic features, pre and/or postnatal 
history and clinical factors (with the potential for 
explaining NS) were collected from medical records and 
from mothers/caregivers in face-to-face interviews. 
 
Data collection – Laboratory methods: Two milliliters 
(2ml) of venous blood was collected twice from each 
neonate by an experienced nurse using two test tubes 
(1ml for each). Each collected blood sample was 
inoculated directly into a tryptone soya broth (1:10 ratio) 
(Oxoid Ltd, UK) and sent to FHRH Medical 
Microbiology Laboratory for culture and antimicrobial 
susceptibility test (AST). All culture broths were 
incubated aerobically at 37°C and observed daily for the 
sign or presence of visible microbial growth up to seven 
days. Sub-culturing was done on blood agar, chocolate 
agar, and MacConkey agar (all Oxoid Ltd, UK). Blood 
and chocolate agar plates were incubated in a candle jar, 
which can generate about 5% CO2. All of the sub-
cultured agar plates were incubated at 37°C and 
examined for visible bacterial growth after 24 hours. For 
samples showing growth on the tryptone soya broth 
and/or sub-culture media, species identification was 
done using biochemical methods (13).  
 
Antimicrobial susceptibility patterns of isolates were 
determined using the Kirby-Bauer disc diffusion 
method. Using a sterile wire loop, loop-full pure 
colonies were suspended in a 5ml sterile normal saline 
(0.85% NaCl) and mixed gently until it formed a 
homogenous suspension. The turbidity of the suspension 
was adjusted to the turbidity of 0.5 McFarland 
standards. The test organisms were uniformly inoculated 
on the surface of Mueller Hinton Agar (MHA) (Oxoid 
Ltd, UK) for non-fastidious group and MHA with 5% 
defibrinated sterile sheep blood for fastidious pathogens. 
The antimicrobial impregnated discs were placed, based 
on the Clinical and Laboratory Standards Institute 
(CLSI) guidelines to the seeded plate with sterile forceps 
and incubated at 37°C for 18 to 24 hours. The antibiotics 
were selected based on the national drug list, frequently 
used in the study area and CLSI recommendation.  
 
The following AST discs were used: gentamicin (GEN: 
10μg), tetracycline (TET: 30μg), 
trimethoprim/sulfamethoxazole (SXT: 25μg), 
erythromycin (ERY: 15μg), penicillin (PEP: 10 unit), 
clindamycin (CLN: 2μg), ampicillin (AMP: 10g), 
ceftriaxone (CTR: 30g), ciprofloxacin (CIP: 5g), 
ceftazidime (CAZ: 30g), cefoxitin (CXT: 30µg) and 
amoxicillin-clavulanic acid (AMC) (30μg) (14). 
 
Data processing and analysis: The collected data were 
checked for completeness and cleaned manually, then 
entered and analyzed using Statistical Package for the 
Social Sciences (SPSS) version 23. Descriptive analysis 
was performed to describe the proportions of NS and 
pathogens. The pattern of AST result was depicted using 
figures and tables. Both bivariate and multivariate 
logistic regressions were computed to identify factors 
associated with NS. The dependent variables were 
bacterial profile and antimicrobial susceptibility pattern. 
The analyzed independent factors were age, sex, 
residence of mother, weight at birth, gestational week, 
place of delivery, mode of delivery, PROM and APGAR 
score. A p-value of ˂0.05 in the multivariate logistic 
regression was considered as a statistically significant 
factor for NS. 
 
Quality Control: The questionnaire was pretested on 5% 
of study participants and subsequently checked for its 
completeness. All types of laboratory activities were 
done as per the standard operating procedure. Daily and 
weekly quality control was done to ensure the sterility 
and performance of the media. To ensure sterility, 5% of 
biochemical test and AST discs, American Type culture 
Collection (ATCC) strains were used and run as clinical 
samples. More specifically, Staphylococcus aureus 
(ATCC-25923) was used as a control representing 
Gram-positive isolates. Similarly, Escherichia coli 
(ATCC-25922) and Pseudomonas aeruginosa (ATCC-
27853) controls delegating Gram-negatives, and that of 
Haemophilus influenzae (ATCC-49247) for fastidious 
bacteria (14), were also used. 
 
Ethical considerations 
Ethical clearance was obtained from Bahir Dar 
University, College of Medicine and Health Sciences 
ethical review board. An official letter of co-operation 
was provided to FHRH prior to data collection. Written 
informed consent was obtained from parents/guardians 
of neonates who participated in the study. The purpose 
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of the study, the procedure, the importance of their 
contribution in the study, risk, and their rights were 
thoroughly explained. All information was coded and 
participants were anonymized. Confidentiality of the 
results was maintained and all results were 
communicated with responsible physicians.  
 
Results 
Socio-demographic and clinical characteristics of the 
participants: Of the total of 412 recruited presumptive 
NS cases in the study, 218 (52.9%) neonates presented 
with EONS. Of the 412 neonates, 219 (53.2%) were 
males. Nearly, 386 (93.7%) of the mothers had sought 
antenatal care (ANC) service and 390 (94.7%) delivered 
in institutions. Of the neonates studied, 130 (31.6%) 
were preterm (<37 weeks of gestation), 146 (35.4%) had 
LBW (<2,500g), 150 (36.4%) were delivered by 
cesarean section (CS), and 31 (8.5%) of the mothers had 
PROM ≥18 hours. The detailed information is 
summarized in Table 1. 
  
Table 1: Socio-demographic characteristics of presumptive neonatal sepsis and mothers at FHRH, Bahir 
Dar, Ethiopia, 2018  
Variable Frequency           Percentage (%) 
Socio-demographic data  
Age of neonates (days)    
  0-3 








  Male  








History of UTI during pregnancy 
  Yes  








  Yes  







Type of delivery 
  Vaginal delivery/SVD  
  CS 









Place of birth 
  Home  







PROM (≥18hrs)  
  Yes  









  <2,500g (LBW)                                







Gestational age (weeks)  
  <37 weeks 
  37-42 weeks 









APGAR score (n=281) 
  <7/1st minute 







APGAR score (n=281) 
  <7/ 5th minute 








Key: LBW = low birth weight; CS = caesarean section; SVD = spontaneous vaginal delivery; APGAR: activity, 
pulse, grimace, appearance and respiration; UTI = urinary tract infection; ANC = antenatal care; PROM = prolonged 
rupture of membrane 
 
Bacterial profile of neonatal sepsis: Of the 412 blood 
samples analyzed, 41.3% ((170/412) at 95% CI: 36-
48%) were positive for pathogenic bacteria, of which 
60% (102/170) were Gram-negative. K. pneumoniae 
and S. aureus were the predominant isolates and gauged 
at 28.2% and 24.7%, respectively (see Table 2). 
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Table 2: Profile of bacterial isolates from culture positive neonates in FHRH, Bahir Dar, Ethiopia, 2018 
(N=170) 
 
Key: CoNS = coagulase-negative Staphylococcus; EONS = early-onset neonatal sepsis; LONS = late-onset 
neonatal sepsis; spp. = species 
 
Antimicrobial susceptibility pattern of bacterial isolates: 
Overall, the resistance pattern of Gram-negative bacteria 
was 61% (62/102), and 39% (27/68) for Gram-positive 
bacteria. The resistance rates of S. aureus and coagulase-
negative Staphylococcus (CoNS) to penicillin were 88% 
and 83%, respectively. Moreover, 38.1% of S. aureus 
and 60.9% of CoNS isolates were resistant to cefoxitin. 
On the other hand, bacterial isolates from NS cases were 
relatively susceptible for ciprofloxacin (82.4%) and 
clindamycin (75%) compared to other antibiotics (see 
Table 3).




























EONS (0-3 days) 
     N (%) 
LONS (>3-28) 
     N (%) 
Total isolates 
    N (%) 
Gram-positive 42 (61.8) 26 (38.2) 68 (40) 
S. aureus 26 (28.9) 16 (20) 42 (24.7) 
CoNS 14 (15.6) 9 (11.3)  23 (13.5)  
Gram-positive 42 (61.8) 26 (38.2) 68 (40) 
S. aureus 26 (28.9) 16 (20) 42 (24.7) 
CoNS 14 (15.6) 9 (11.3)  23 (13.5)  
S. pyogenes 2 (2.2) 1 (1.3) 3 (1.8) 
Gram-negative 48 (47.1) 54 (53.9) 102 (60) 
K. pneumoniae 26 (54.2) 22 (45.8) 48 (28.2) 
E. coli    15 (62.5) 9 (37.5) 24 (14.1) 
K. ozaenae 2 (22.2) 7 (77.8) 9 (5.3) 
Citrobacter spp. 3 (37.5) 5 (62.5) 8 (4.7) 
Total  90 (52.9) 80 (47.1) 170 (100) 
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                     Table 3: Antimicrobial susceptibility pattern of Gram-positive bacteria isolated from neonates’ blood culture in FHRH, Bahir Dar, Ethiopia, 2018 (N=68)  
 
Key: S = sensitive; I = intermediate; R = resistant; CoNS = coagulase-negative Staphylococcus; GEN = gentamicin; CIP = ciprofloxacin; CTR = ceftriaxone;  
                    SXT = trimethoprim/sulfamethoxazole; TET = tetracycline; CLN = clindamycin; ERY = erythromycin; PEP = penicillin; CXT = cefoxitin 
 
 
Regarding Gram-negative isolates, K. pneumoniae was 100% and 81% resistant to ampicillin and amoxicillin-clavulanate, respectively. For E. coli isolates, 92% developed 
resistance to ampicillin and 71% developed resistance to both tetracycline and amoxicillin-clavulanate. P. aeruginosa was highly resistant to the majority of antibiotics; 67% 




























) S 27 (64.2) 34 (81.0) 26 (61.9) 26 (62.0) 22 (52.4) 31 (74.0) 14 (33.3) 5 (12.0) 24 (57.1) 23 (54.8) 
I 2 (4.8) 2 (5.0) 3 (7.1) 1 (2.4) 5 (11.9) 3 (7.0) 0 (0.0) 0 (0.0) 2 (4.8) 2 (4.7) 











S 16 (69.5) 19 (82.6) 11 (47.8) 14 (61.9) 10 (43.5) 17 (74.0) 9 (39.2) 4 (17.0) 8 (34.8) 12 (52.2) 
I 0 (0.0) 1 (4.4) 2 (8.7) 0 (0.0) 2 (8.7) 1 (4.3) 1 (4.3) 0 (0.0) 1 (4.3) 1 (4.3) 













S 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 










S 46 (67.7) 56 (82.4) 40 (58.8) 43 (63.2 35 (51.5) 51 (75.0) 26 (38.2) 12 (17.5) 35 (51.5) 38 (55.9) 
I 2 (2.9) 3 (4.4) 5 (7.4) 1 (1.5) 7 (10.3) 4 (5.9) 1 (1.5) 0 (0.0) 3 (4.4) 3 (4.4) 
R 20 (29.4) 9 (13.2) 23 (33.8) 24 (35.3) 26 (38.2) 13 (19.1) 41 (60.3) 56 (82.5) 30 (44.1) 27 (39.7) 
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Table 4: Antimicrobial susceptibility pattern of Gram-negative isolates from NS in FHRH, Bahir Dar, Ethiopia, 2018 (N=102) 
Key: S = sensitive; I = intermediate; R = resistant; spp. = species; AMP = ampicillin; GEN = gentamicin; CIP = ciprofloxacin; CTR = ceftriaxone; SXT = 




Antimicrobial agents N (%) Total N (%) 
AMP GEN CIP CTR SXT TET AMC CAZ 
K. pneumoniae (n=48) S 0 (0) 16 (33) 35 (73) 17 (35) 11 (23) 16 (33) 7 (14) 22 (45) 16 (33) 
I 0 (0) 2 (4) 2 (4) 3 (6) 3 (6)  5 (11) 2 (4) 5 (11) 3 (6) 
R 48 (100) 30 (63) 11 (23) 28 (59) 34 (71) 27 (56) 39 (81) 21 (44) 30 (61) 
E. coli (n=24) S 2 (8) 19 (79) 21 (87) 12 (50) 7 (29) 7 (29) 6 (25) 13 (54) 11 (46) 
I 0 (0) 0 (0) 0 (0) 3 (13) 1 (4) 0 (0) 1 (4) 2 (8) 1 (4) 
R 22 (92) 5 (21) 3 (13) 9 (37) 16 (67) 17 (71) 17 (71) 9 (38) 12 (50) 
K. ozaenae (n=9) S 0 (0) 2 (22) 6 (67) 3 (33) 2 (22) 1 (11) 4 (45) 5 (56) 2 (22) 
I 0 (0) 1 (11) 0 (0) 1 (11) 0 (0) 0 (0) 2 (22) 2 (22) 1 (11) 
R 9 (100) 6 (67) 3 (33) 5 (56) 7 (78) 8 (89)  3 (33) 2 (22) 6 (67) 
Citrobacter spp. (n=8) S 0 (0) 4 (50) 6 (75) 1 (13) 4 (50) 3 (38) 4 (50) 5 (63) 3 (37) 
I 1 (12) 0 (0) 0 (0) 1 (12) 1 (12) 2 (25) 0 (0) 0 (0) 1 (13) 
R 7 (88) 4 (50) 2 (25) 6 (75) 3 (38) 3 (38) 4 (50) 3 (38) 4 (50) 
Acinetobacter spp. (n=5) S 0 (0) 1 (20) 3 (33) 0 (0) 0 (0) 1 (20) 1 (20) 1 (20) 1 (20) 
I 0 (0) 0 (0) 0 (0)  0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
R 5 (100) 4 (80) 2 (67) 5 (100) 5 (100) 4 (80) 4 (80) 4 (80) 4 (80) 
Enterobacter spp. (n=5) S 0 (0) 1 (20) 2 (40) 0 (0) 1 (20) 3 (60) 1 (20) 2 (40) 1 (20) 
I 0 (0) 0 (0) 0 (0) 2 (40) 0 (0) 0 (0) 1 (20) 0 (0) 0 (0) 
R 5 (100) 4 (80) 3 (60) 3 (60) 4 (80) 2 (40) 3 (60) 3 (60) 4 (80) 
P. aeruginosa (n=3) S 0 (0) 0 (0) 1 (33) 1 (33) 0 (0) 0 (0) 0 (0) 2 (67) 0.5 (10) 
I 0 (0) 0 (0) 0 (0)  0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
R 3 (100) 3 (100) 2 (67) 2 (67) 3 (100) 3 (100) 3 (100) 1 (33) 2.5 (90) 
Total isolates (n=102) S 2 (2) 43 (42) 74 (73) 34 (33) 25 (25) 31 (30) 23 (23) 50 (49) 35 (34) 
I 1 (1) 3 (3) 2 (2) 10 (10) 5 (5) 7 (7) 6 (6) 9 (9) 5 (5) 
R 99 (97) 56 (55) 26 (25) 58 (57) 71 (70) 64 (63) 73 (72) 43 (42) 62 (61) 
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The overall multidrug resistance (MDR) rate of isolates 
from NS was 78.2% (133/170). Of these, 67.7% 
(90/133) of the MDR isolates were Gram-negative 
bacteria and 32.3% (43/133) were Gram-positive (see 
Table 5).  
 
Table 5: Multidrug-resistance pattern of bacterial isolates among isolates from NS cases in FHRH, Bahir 
Dar, Ethiopia, 2018 (n=170) 
 
Organism isolated 




R0 R1 R2 R3 R4 R5 ≥R6 Total (%) 
Gram-positive (n=68) 4 (5.9) 1 (1.5) 19 (27.9) 7 (10.3) 20 (29.4) 4 (5.9) 12 (17.6) 43 (63.2) 
  S. aureus (n=42) 1 (2.4) 1 (2.4) 12 (28.6) 3 (7.1) 16 (38) 3 (7.1) 5 (11.9) 27 (64.3) 
  CoNS (n=23) 0 (0.0) 0 (0.0) 7 (30.4) 4 (17.4) 4 (17.4) 1 (4.3) 7 (30.4) 16 (69.6) 
  S. pyogenes (n=3) 3 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Gram-negative (n=102) 0 (0.0) 3 (2.9) 9 (8.8) 5 (4.9) 26 (25.5) 24 (23.5) 35 (34.3) 90 (88.2) 
  K. pneumoniae (n=48) 0 (0.0) 0 (0.0) 3 (6.3) 4 (8.3) 13 (27.1) 9 (18.8) 19 (39.6) 45 (93.8) 
  E. coli (n=24) 0 (0.0) 2 (8.3) 4 (16.7) 1 (4.2) 5 (20.8) 8 (33.3) 4 (16.7) 18 (75.0) 
  K. ozaenae (n=9) 0 (0.0) 0 (0.0) 1 (11) 0 (0.0) 3 (33.0) 3 (33.3) 2 (22.2) 8 (88.9) 
  Citrobacter spp. (n= 8) 0 (0.0) 1(12.5) 1 (12.5) 1 (12.5) 4 (50.0) 1 (12.5) 1 (12.5) 7 (87.5) 
  Acinetobacter spp. 
(n=5) 
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (100) 5 (100) 
  Enterobacter spp. 
(n=5) 
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (20) 3 (60) 1 (20.0) 5 (100) 
  P. aeruginosa (n=3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (100) 3 (100) 
Total (n=170) 4 (2.3) 4 (2.3) 28 (16.5) 12 (7) 46 (27) 28 (17) 47 (28) 133 (78.2) 
Key: CoNS = coagulase-negative Staphylococcus; spp. = species; R0 = susceptible to all antibiotics; R1 = resistant 
to one antibiotic class; R2 = resistant to two antibiotic classes; R3 = resistant to three antibiotic classes; R4 = 
resistant to four antibiotic classes; R5 = resistant to five antibiotic classes; ≥R6 = resistant to six or more antibiotic 
classes; MDR = multidrug resistance 
 
Factors associated with neonatal sepsis: In the 
bivariate analysis, variables with a p-value of <0.2 
were included in the multivariate analysis. In the final 
multivariate analysis, delivery by CS [AOR = 2.826; 
95% CI: 1.618, 4.936], gestational age <37 weeks 
[AOR = 2.049; 95% CI: 1.151, 3.647], LBW [AOR = 
2.357; 95% CI: 1.352, 4.109] and PROM (≥18 hours) 
[AOR = 4.282; 95% CI: 1.615, 11.354] demonstrated 
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Bacteria isolated Bivariate analysis Multivariate analysis 
Yes (%) No (%) COR (95% CI) AOR (95% CI)      
Mode of delivery 
  SVD  
  CS 











2.361 (1.548, 3.600) 
1.928 (0.885, 4.198) 
 
1 
2.826 (1.618, 4.936)* 
2.480 (0.945, 6.508) 
Gestational age 
  37-42 weeks 









1.935 (1.270, 2.949) 
 
1 
2.049 (1.151, 3.647)*  
Birth weight 
  ≥2,500 gram  









2.711 (1.789, 4.108) 
 
1 
2.357 (1.352, 4.109)* 
History of UTI 
  No 









1.659 (0.849, 3.241) 
 
1 
1.811 (0.793, 4.135) 
PROM (≥ 18 hours) 
  No 









4.577 (1.995, 10.501) 
 
1 
4.282 (1.615, 11.354)*      
APGAR score (n=281) 
  ≥ 7/minute 5 
  < 7/minute 5 
APGAR score (n=281) 
  ≥ 7/minute 1 
































1.441 (0.578, 3.593) 
Key: LBW = low birth weight; PROM = prolonged rupture of membrane; APGAR = activity, pulse, grimace, 
appearance and respiration; COR = crude odds ratio; AOR = adjusted odds ratio; CI = confidence interval; 
*statistically associated  
 
Discussion 
The proportion of NS was 41.3% (95% CI: 36-48%), 
which is a very high rate. Similar findings have been 
documented in Addis Ababa (44.7%) (15) and Gondar 
(46.6%) (16), in Ethiopia, and in Egypt (40.7%) (17) 
and India (44%) (18). On the other hand, the proportion 
of NS in our study (41.3%) was higher than studies 
conducted in Gondar (32.1%) (19), Tanzania 19.2% 
(20), Nigeria (22.4%) (21) and Pakistan (7.2%) (22) 
and (21.1%) (23).The proportion of NS in the current 
study was lower compared to studies in Sudan (61.3%) 
(24) and India (54.1%) (25). The discrepancy in the 
findings could be explained by several factors, 
including differences in the habits of infection 
prevention practices, living conditions and variability 
in the management of antibiotics.  
 
Gram-negative bacteria were responsible for 60% of 
NS. This could be due to the low level of maternal 
immunoglobulin G ability towards opsonization 
against Gram-negative bacteria than Gram-positive 
bacteria (26,27). Moreover, the Enterobacteriaceae 
families are the abundant normal gastrointestinal 
microbiota, but are a potential pathogen outside of that 
site. This finding is consistent with studies reported by 
Gebrehiwot et al. (62%) in Gondar (19), Ali et al. 
(60%) in Iraq (28), and Jayasimha et al. (62.5%) in 
India (20). Klebsiella pneumoniae was the 
predominant isolate, 48 (28.2%), which is similar to 
other studies (16, 24, 25, 29, 30). This could be due to 
its high capsulated nature and its ability to form a thick 
layer of biofilm on medical devices and surrounding 
areas (31). The proportion of S. aureus was 24.7% 
(42/170) and that of CoNS was 13.5% (23/170) among 
Gram-positive isolates. These bacteria are often skin 
colonizers that probably enter the bloodstream during 
medical procedures, thereby causing NS (32). This 
finding is in agreement with studies conducted 
elsewhere (16,24,25,29,30).  
 
From this study, antimicrobial resistance patterns were 
assessed. S. aureus and CoNS were resistant to 
penicillin, whereas K. pneumoniae was highly resistant 
to ampicillin and amoxicillin-clavulanate. The overuse 
of antibiotics, and/or use of drugs without laboratory 
confirmation could be the explanatory factor (33). 
Overall, Gram-negative isolates showed a higher MDR 
rate. Similarly, a high proportion of Gram-negative 
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MDR bacteria were reported by Gebrehiwot et al. (19). 
This might be due to the fact that Gram-negative 
bacteria have a high ability of gene transfer 
mechanism, intrinsic antibiotic resistance and beta-
lactamase production (34). Particularly, extreme MDR 
(100%) was found in P. aeruginosa and Acinetobacter 
species. This might be due to a combination of beta-
lactamase production, an increased efflux pump 
activity, and outer membrane modifications of the 
bacteria (35).  
The probability of developing sepsis among neonates 
delivered by CS was 2.8 times greater than normal 
delivery [AOR = 2.826; 95% CI: 1.618, 4.936]. 
Previous studies corroborate this result (17,16,36). 
This could be due to the fact that CS is medically 
indicated for mothers who have a sign of labor 
complication, such as long duration of labor, PROM 
≥18 hours, obstructed labor, foetal distress and mal-
presentation (37,38). 
  
In line with the present study, several lines of evidence 
show that neonates with a gestational age less than 37 
weeks are more likely to develop NS in Ethiopia 
(15,16), and in other studies worldwide 
(3,28,36,39,40). The possible reason for this could be a 
decreased production of neutrophils and low 
concentrations of immunoglobulin occurring in 
preterm neonates (26,38,41,42). Another probable 
reason might be the absence of trans-placental passage 
of complement and other immunoglobulin (such as 
IgA) (26). Moreover, preterm neonates have less 
activation of complement components and are unable 
to prevent the colonization of pathogenic bacteria on 
the mucosal membrane (26). 
 
In our study, LBW neonates were 2.5 times more likely 
to develop sepsis than normal birth weight neonates 
[AOR = 2.546; 95% CI: 1.409, 4.600]. This finding is 
supported by previous studies in Ethiopia (15,16) and 
elsewhere (17,28,36). The LBW neonatal skin is 
functionally still in development, and the incomplete 
maturation may lead to the entrance of bacteria to cause 
systemic infections (42). Immaturity of the immune 
system, frequent resuscitation, longer hospital stay and 
invasive procedures (nutritional or breathing support) 
are also common in LBW babies, compared to the 
normal birth weight counterparts (26). 
 
Mothers with PROM ≥18 hours were four times more 
likely to develop sepsis compared to neonates born 
from mothers who had PROM <18hrs. This is in line 
with studies done in Ethiopia (44) and Tanzania (39). 
In most cases, the foetus is not exposed to pathogenic 
bacteria until the membranes rupture. However, 
pathogens might infect the foetus through ascending 
via the amniotic fluid, placenta, cervix, or vaginal canal 
(26,45,46).  This finding is also found in related studies 
(21,47). Mothers with a history of UTI and APGAR <7 
did not show any association with NS.  
 
Conclusions  
High proportions of NS presumptive cases were 
positive for pathogenic bacteria. K. pneumoniae and S. 
aureus were the leading recovered pathogens. Gram-
negative isolates demonstrated a high rate of resistance 
to ampicillin, and the Gram-positive isolates were 
more resistant to penicillin. The majority of recovered 
pathogens in NS were susceptible to ciprofloxacin. The 
overall prevalence of MDR was high. Preterm, CS, 
LBW and PROM ≥18 hours showed statistical 
association with NS. 
 
Taken together, the results of this study provide a 
glimpse into NS epidemiology in one of the biggest 
referral hospitals in Ethiopia. The study could be used 
as baseline information for further studies. 
Additionally, in the absence of other high-quality 
evidence, the study can be a base for empirical 
treatment decisions. However, bias may have been 
introduced given that this was a single facility-based 
study, with a low sample size, design effect, and a 
convenient sampling technique. The quality of the 
evidence is low and caution must be taken in 
interpreting and extrapolating from the findings. As 
such, further research is highly desirable.  
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